ImpediMed Limited IPDQF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.91M | -16.30M | -15.71M | -15.31M | -15.03M |
| Total Depreciation and Amortization | 210.30K | 279.40K | 346.10K | 373.10K | 422.60K |
| Total Amortization of Deferred Charges | 2.65M | 2.59M | 2.53M | 2.53M | 2.53M |
| Total Other Non-Cash Items | 2.56M | 1.81M | 1.09M | 923.60K | 771.90K |
| Change in Net Operating Assets | -647.30K | 284.70K | 1.20M | 1.20M | 1.20M |
| Cash from Operations | -12.14M | -11.33M | -10.55M | -10.29M | -10.11M |
| Capital Expenditure | -47.10K | -42.50K | -38.00K | -38.00K | -38.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -340.70K | -128.60K | 78.90K | 52.20K | 24.70K |
| Cash from Investing | -387.70K | -171.00K | 40.90K | 14.20K | -13.30K |
| Total Debt Issued | 7.68M | 15.66M | 23.64M | 19.81M | 15.97M |
| Total Debt Repaid | -5.31M | -2.84M | -373.00K | -397.50K | -422.00K |
| Issuance of Common Stock | 15.30M | 7.65M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.66M | -4.01M | -3.35M | -2.63M | -1.90M |
| Cash from Financing | 8.85M | 10.82M | 12.76M | 10.70M | 8.64M |
| Foreign Exchange rate Adjustments | -1.01M | -1.30M | -1.58M | -925.70K | -258.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.69M | -1.98M | 660.30K | -505.70K | -1.74M |